Compare CARV (CARV) vs Enzyme (MLN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
CARV vs Enzyme — how do they compare? CARV trades at Rp520.23 (market cap Rp344,38M, Rp17,77M 24h volume), while Enzyme trades at Rp30,212 (market cap Rp134,13M, Rp104,56M 24h volume). The key difference: CARV is far larger — about 2.6× Enzyme's market cap, and CARV's circulating supply is 662,9M CARV versus 3,3M MLN for Enzyme. Which is the better fit depends on your goals — on Pluang, investors hold CARV for 26 Days and Enzyme for 29 Days on average.
| CARV | MLN | |
|---|---|---|
Market Cap | Rp344,38M | Rp134,13M |
Volume (24h) | Rp17,77M | Rp104,56M |
Circulating Supply | 662,9M CARV | 3,3M MLN |
Typical Hold Time | 26 Days | 29 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CARV is currently trading at Rp529.48 with a market cap of Rp351.39 million, showing a bullish technical signal despite bearish moving averages. The token trades near the pivot point of Rp532, with key support at Rp519 and resistance at Rp544. Hold time of 26 days indicates moderate holding patterns among investors.
Overall outlook remains cautiously optimistic with strong ADX signals indicating trend strength. Key opportunities include potential breakout above Rp544 resistance, while risks include limited liquidity and typical crypto volatility. Investors should monitor volume patterns and broader market sentiment.
Enzyme (MLN) shows limited market activity with a modest market cap of Rp134,13M and circulating supply of 3,3jt tokens. The asset demonstrates relatively low volatility with an average hold time of 29 days, suggesting stable holder behavior. Trading volumes appear subdued across exchanges, indicating limited speculative interest. No significant protocol upgrades or ecosystem developments have been reported recently, though the project continues to operate its decentralized asset management platform.
Overall outlook remains cautious due to limited liquidity and trading activity. Key opportunities include potential ecosystem growth in decentralized finance asset management, while major risks include low market depth, regulatory uncertainty for DeFi protocols, and competition from larger DeFi platforms. The token's utility within its native protocol remains its primary value driver.
About CARV
CARV SVM Chain is an AI-driven infrastructure that enhances the capabilities of the Solana Virtual Machine (SVM) by integrating it with the Ethereum network. This combination leverages Solana's scalability alongside Ethereum's robust security features. The SVM Chain also empowers native AI agents to autonomously manage and interact with data from start to finish. To ensure privacy, it utilizes zero-knowledge technology and trusted execution environments (TEEs).
Read more on CARV →About Enzyme
Enzyme is an easy-to-use on-chain asset management system that enables access to digital assets and DeFi from one simple, unified app. It provides a front-to-back execution and order management system, which provides fully automated reporting, risk management, administration, governance and operations.
Read more on MLN →
